Zlatko Fras

2007–2025 年に発表

66
論文数
28,737
被引用数
40
h 指数
62
i10 指数

被引用数

Zlatko Fras の年別被引用数1969 年: 被引用 1 件1985 年: 被引用 2 件1997 年: 被引用 1 件1998 年: 被引用 3 件2003 年: 被引用 5 件2004 年: 被引用 1 件2005 年: 被引用 2 件2007 年: 被引用 1 件2009 年: 被引用 3 件2010 年: 被引用 8 件2011 年: 被引用 54 件2012 年: 被引用 58 件2013 年: 被引用 118 件2014 年: 被引用 127 件2015 年: 被引用 103 件2016 年: 被引用 156 件2017 年: 被引用 167 件2018 年: 被引用 195 件2019 年: 被引用 827 件2020 年: 被引用 1,261 件2021 年: 被引用 1,324 件2022 年: 被引用 1,220 件2023 年: 被引用 1,002 件2024 年: 被引用 1,615 件2025 年: 被引用 668 件2026 年: 被引用 29 件1970〜1984 年は被引用が無いため表示していません1986〜1996 年は被引用が無いため表示していません1999〜2002 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,093 件、この内訳の 11.9%イギリス: 引用元論文 1,363 件、この内訳の 7.8%イタリア: 引用元論文 1,272 件、この内訳の 7.2%中国: 引用元論文 954 件、この内訳の 5.4%ドイツ: 引用元論文 869 件、この内訳の 5%オランダ: 引用元論文 721 件、この内訳の 4.1%スペイン: 引用元論文 693 件、この内訳の 4%オーストラリア: 引用元論文 548 件、この内訳の 3.1%フランス: 引用元論文 530 件、この内訳の 3%スウェーデン: 引用元論文 527 件、この内訳の 3%カナダ: 引用元論文 521 件、この内訳の 3%ポーランド: 引用元論文 507 件、この内訳の 2.9%
0%11.9%その他 39.6%

分野

  • Medicine81.4%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Nursing2%
  • Health Professions1.9%
  • Immunology and Microbiology1.5%
  • Environmental Science0.8%
  • その他4.6%

トピック

  • Lipoproteins and Cardiovascular Health10.8%
  • Diabetes, Cardiovascular Risks, and Lipoproteins6.3%
  • Cardiac Health and Mental Health3.5%
  • Atherosclerosis and Cardiovascular Diseases2.2%
  • Cardiac Imaging and Diagnostics2.1%
  • Acute Myocardial Infarction Research2%
  • その他73.1%

共著者

全論文

検索で開く
  1. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ESC Scientific Document Group, Guy De Backer, Vera Regitz‐Zagrosek, Anne Hege Aamodt, Magdy Abdelhamid, Victor Aboyans, Christian Albus, Riccardo Asteggiano, Magnus Bäck, Michael A. Borger, Carlos Brotons, Jelena Čelutkienė, Renata Cífková, Maja Čikeš, Francesco Cosentino, Nikolaos Dagres, Tine De Backer, Dirk De Bacquer, Victoria Delgado, Hester M. den Ruijter, Paul Dendale, Heinz Drexel, Volkmar Falk, Laurent Fauchier, Brian A. Ference, Jean Ferrières, Marc Ferrini, Miles Fisher, Danilo Fliser, Zlatko Fras, Dan Gaiță, Simona Giampaoli, Stephan Gielen, Ian Graham, Catriona Jennings, Torben Jørgensen, Alexandra Kautzky‐Willer, Maryam Kavousi, Wolfgang Köenig, А. О. Конради, Dipak Kotecha, Ulf Landmesser, Madalena Lettino, Basil S. Lewis, Aleš Linhart, Maja‐Lisa Løchen, Konstantinos Makrilakis, Giuseppe Mancia, Pedro Marques‐Vidal, John W. McEvoy, Paul McGreavy, Béla Merkely, Lis Neubeck, Jens Cosedis Nielsen, Joep Perk, Steffen E. Petersen, Anna Sonia Petronio, Massimo Piepoli, Nana Goar Pogosova, Eva Prescott, Kausik K. Ray, Željko Reiner, Dimitrios Richter, Lars Rydén, Е. V. Shlyakhto, Marta Sitges, Miguel Sousa‐Uva, Isabella Sudano, Monica Tiberi, Rhian M. Touyz ほか 33 名 - European Heart Journal 2021 被引用: 6,270

  2. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Basil S. Lewis, Bela Merkely, Christian Mueller, Steffen E. Petersen, Anna Sonia Petronio, Dimitrios J. Richter, Marco Roffi, Е. V. Shlyakhto, Iain A. Simpson, Miguel Sousa‐Uva, Rhian M. Touyz, Djamaleddine Nibouche, Parounak Zelveian, Peter Siostrzonek, Ruslan Najafov, Philippe van de Borne, Belma Pojskić, Arman Postadzhiyan, Lambros Kypris, Jindřich Špinar, Mogens Lytken Larsen, Hesham Salah Eldin, Margus Viigimaa, Timo Strandberg, Jean Ferrières, Rusudan Agladze, Ulrich Laufs, Loukianos Rallidis, László Bajnok, Thorbjörn Gudjónsson, Vincent Maher, Yaakov Henkin, Michele Massimo Gulizia, A Mussagaliyeva, Gani Bajraktari, Alina Kerimkulova, Gustavs Latkovskis, Omar Hamoui, Rimvydas Šlapikas, Laurent Visser, Philip Dingli, Victoria Ivanov, Aneta Bošković, M Nazzi, Frank L.J. Visseren, Irena Mitevska, Kjetil Retterstøl, Piotr Jankowski, Ricardo Fontes‐Carvalho, Dan Gaiță, М. В. Ежов, Marina Foscoli, Vojislav Giga, Daniel Pella, Zlatko Fras, Leopoldo Pérez de Isla, Emil Hagström, Roger Lehmann, Leïla Abid, Öner Özdoğan, Olena Mitchenko, Riyaz Patel - Atherosclerosis 2019 被引用: 4,864

  3. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen J. Bax, H. Baumgartner, Claudio Ceconi, V. Dean, Christi Deaton, Robert Fagard, Christian Funck‐Brentano, David Hasdai, A. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa A. McDonagh, Bruno Moulin, Bogdan A. Popescu, Z. Reiner, U Sechtem, P. A. Sirnes, Michał Tendera, Adam Torbicki, A. Vahanian, Stephan Windecker, Document Reviewers:, Christian Funck‐Brentano, P. A. Sirnes, Victor Aboyans, Eduardo Alegría Ezquerra, Colin Baigent, Carlos Brotons, G. Burell, Antonio Ceriello, Johan De Sutter, J. Deckers, Stefano Del Prato, H.‐C. Diener, Donna Fitzsimons, Zlatko Fras, Rainer Hambrecht, Piotr Jankowski, U Keil, Mike Kirby, Mogens Lytken Larsen, Giuseppe Mancia, Athanasios Manolis, John J.V. McMurray, A. Pajak, Alexander Parkhomenko, Loukianos Rallidis, Fausto Rigo, Evangelista Rocha, Luís M. Ruilope, Enno T. van der Velde, Diego Vanuzzo, Margus Viigimaa, Massimo Volpe, Olov Wiklund, C. Wolpert - European Heart Journal 2012 被引用: 8,519

  4. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 被引用: 572

  5. European Society of Cardiology: Cardiovascular Disease Statistics 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margus Viigima, Pietila Mikko Juhani, Yves Juillière, Simon Cattan, Alexander Aladashvili, Christian Hamm, Karl‐Heinz Kück, Konstantinos Papoutsis, Kurt Bestehorn, Stefanos Foussas, Georgia Giannoulidou, Christos Varounis, Ioannis Kallikazaros, Róbert Gábor Kiss, Tunde Czétényi, Dávid Becker, Þórarinn Guðnason, Peter Kearney, Kenneth J McDonald, Yoseph Rozenman, Batia Ziv, Leonardo Bolognese, Paola Luciolli, Giuseppe Boriani, Salim Berkinbayev, Amina Rakisheva, Erkin М Мirrakhimov, Andrejs Ērglis, Sandra Jegere, Germanas Marinskis, Jean Beissel, Nathalie Marchal, Sasko Kedev, Robert G. Xuereb, Terence Tilney, Tiziana Felice, M Popovici, Jeroen Bax, Barbara J.M. Mulder, Maarten Simoons, Moniek Elsendoorn, Terje K. Steigen, Dan Atar, Zbigniew Kalarus, Michał Tendera, José Silva‐Cardoso, José Paulo Agner Ribeiro, Cristina Cruz Mateus, Gabriel Tatu-Chitoiu, Petar Seferovic, Branko Beleslin, Iveta Šimková, Petra Durcikova, Veronica Belicova, Zlatko Fras, Sasa Radelj, José Ramón González‐Juanatey, Sharon Legendre, Frieder Braunschweig, Urs Philipp Kaufmann, Marjam Rüdiger-Stürchler, Lâle Tokgözoğlu, Ahmet Unver, В. Н. Коваленко, E. G. Nesukay, Anastasia Naum, Paola Thellung de Courtelary, Stéphan Martin, David Sebastiao, Daval Ghislain ほか 2 名 - European Heart Journal 2017 被引用: 951

  6. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nebojša Lalić, Seppo Lehto, Dragan Lović, S. Mancas, Linda Mellbin, Davor Miličić, Erkin М Мirrakhimov, Р. Г. Оганов, Nana Pogosova, Željko Reiner, Stefan Störk, Lâle Tokgözoğlu, Costas Tsioufis, Duško Vulić, David Wood, on behalf of the EUROASPIRE Investigators* - European Journal of Preventive Cardiology 2019 被引用: 937

  7. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Harrington, J. Wouter Jukema, Michael Szarek, Harvey D. White, Andreas M. Zeiher, Pierluigi Tricoci, Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina Gotcheva, Juan Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Željko Reiner, Petr Ostadal, Margus Viigimaa, Markku S. Nieminen, Vakhtang Chumburidze, Nikolaus Marx, Nicolas Danchin, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, K. Yusoff, Gabriel Arturo Ramos López, Marco Alings, Sigrun Halvorsen, Roger M. Correa Flores, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H Asita de Silva, Emil Hagström, Ulf Landmesser, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Robert A. Vogel ほか 1,603 名 - The Lancet Diabetes & Endocrinology 2019 被引用: 328

  8. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Diaz, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lopes, Nina Gotcheva, Shaun G. Goodman, Juan-Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ošťádal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung-Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang-Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M. Correa Flores, Rody G. Sy, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen D. Ristic, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Matthew T. Roe, Robert A. Vogel, Bernard Chaitman ほか 1,652 名 - Journal of the American College of Cardiology 2021 被引用: 141

  9. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Díaz, Philip E Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina N Gotcheva, Shaun G. Goodman, Juan Carlos Prieto, Huo Yong, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ostadal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos, Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo-Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M Correa Flores, Rody G. Sy, Andrzej Budaj, João Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Ján Murín, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty ほか 1,635 名 - Circulation 2022 被引用: 122

  10. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Johan De Sutter, Jaap W. Deckers, Mirza Dilić, М. М. Долженко, H. Druais, Vilnis Dzērve, Andrejs Ērglis, Zlatko Fras, D. Gaita, Nina Gotcheva, D.E. Grobbee, Viveca Gyberg, Hosam Hasan Ali, Peter U. Heuschmann, Arno W. Hoes, Piotr Jankowski, Nebojša Lalić, Seppo Lehto, Dragan Lović, Aldo P. Maggioni, S. Mancas, Pedro Marques‐Vidal, Linda Mellbin, Davor Miličić, E. Mirrakhimov, Р. Г. Оганов, Nana Pogosova, Željko Reiner, Lars Rydén, Martin Stagmo, Stefan Störk, Jouko Sundvall, Lâle Tokgözoğlu, Konstantinos Tsioufis, Duško Vulić, David Wood, David A. Wood, Kornelia Kotseva, Catriona Jennings, Agnieszka Adamska, S. Adamska, Lars Rydén, Linda Mellbin, J. Tuomilehto, Oliver Schnell, H. Druais, Edoardo Fiorucci, Myriam Glémot, Florian Larras, V. Missiamenou, Aldo P. Maggioni, C. Taylor, Teresa Ferreira, Katell Lemaitre, Dirk De Bacquer, Guy De Backer, Laura Råman, Jouko Sundvall, Daniel-Henri Desmedt, Johan De Sutter, Anne‐Marie Willems, Michel De Pauw, Pieter Vervaet, J. Bollen, E. Dekimpe, N. Mommen, G. Van Genechten, Paul Dendale, C A Bouvier, Patrick Chenu ほか 475 名 - Atherosclerosis 2019 被引用: 369

  11. Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2020 被引用: 209

  12. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Željko Reiner, Martin Stagmo, Stefan Störk, Lâle Tokgözoğlu, Duško Vulić, on behalf of the EUROASPIRE Investigators - European Journal of Preventive Cardiology 2015 被引用: 1,004

  13. Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)

    著者: , , , , , , , , , - Cardiovascular Diabetology 2022 被引用: 101

  14. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djurić, Ronen Durst, М. В. Ежов, Zlatko Fras, Dan Gaiță, Ioanna Gouni‐Berthold, Adrían V. Hernández, Steven R. Jones, Jacek Jerzy Jozwiak, N. Kakauridze, Amani Kallel, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martínez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin М Мirrakhimov, André R. Miserez, Olena Mitchenko, N. P. Mitкоvsкаyа, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Peter E. Penson, Žaneta Petrulionienė, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenković, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Amirhossein Sahebkar, Maria-Corina Șerban, Abdullah Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Tóth, Margus Viigimaa, Pedro Valdivielso, Dragoş Vinereanu, Branislav Vohnout, Stephan von Haehling, Michal Vrablı́k, Nathan D. Wong, Hung‐I Yeh, Jiang Zhisheng, Andreas Zirlik - Pharmacological Research 2023 被引用: 68

  15. Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

    著者: , , , , , , , , , , , , , , , , , - European Heart Journal 2023 被引用: 46

  16. Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

    著者: , , , , , , , , , , , - Progress in Cardiovascular Diseases 2023 被引用: 72

  17. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , N. Kakauridze, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martínez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin М Мirrakhimov, André R. Miserez, Olena Mitchenko, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Peter E. Penson, Žaneta Petrulionienė, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Amirhossein Sahebkar, Naveed Sattar, Maria-Corina Șerban, Abdulla Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Tóth, Margus Viigimaa, Dragoş Vinereanu, Branislav Vohnout, Stephan von Haehling, Michal Vrablı́k, Nathan D. Wong, Hung‐I Yeh, Jiang Zhisheng, Andreas Zirlik - Clinical Nutrition 2020 被引用: 137

  18. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nutrition Reviews 2017 被引用: 287

  19. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zlatko Fras, Jacques Genest, Urh Grošelj, Mariko Harada‐Shiba, Meral Kayıkçıoğlu, Katarina Lalić, Carolyn S.P. Lam, Gustavs Latkovskis, Ulrich Laufs, Evangelos Liberopoulos, Jie Lin, Vincent Maher, Nelson Majano, Adéle Marais, Winfried März, Erkin М Мirrakhimov, André R. Miserez, Olena Mitchenko, Hapizah Nawawi, Børge G. Nordestgaard, György Paragh, Žaneta Petrulionienė, Belma Pojskić, Arman Postadzhiyan, Ashraf Reda, Željko Reiner, Wilson E. Sadoh, Amirhossein Sahebkar, Abdullah Shehab, Aleksander B. Shek, Mario Stoll, Ta‐Chen Su, Tavintharan Subramaniam, Andrey V. Susekov, Phivos Symeonides, Myra Tilney, Brian Tomlinson, Thanh‐Huong Truong, Alexandros D. Tselepis, Anne Tybjærg‐Hansen, Alejandra Vázquez-Cárdenas, Margus Viigimaa, Branislav Vohnout, Elisabeth Widén, Shizuya Yamashita, Maciej Banach, Dan Gaiță, Lixin Jiang, Lennart Nilsson, Lourdes Ella G. Santos, Heribert Schunkert, Lâle Tokgözoğlu, Josip Car, Alberico L. Catapano, Kausik K. Ray - Atherosclerosis 2018 被引用: 238

  20. Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials

    著者: , , , , , , , , , , , , , , - Pharmacological Research 2019 被引用: 128

  21. Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE Risk Model

    著者: , , , , , , , , , , , , , , , , - European Journal of Preventive Cardiology 2020 被引用: 63

  22. Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group

    著者: , , , , , , , , , , , , , , , , , - Diabetes Therapy 2024 被引用: 43

  23. Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dimitri P. Mikhailidis - Archives of Medical Science 2015 被引用: 385

  24. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Archives of Medical Science 2017 被引用: 288